rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jennifer Carver

Director

Company insider

Files Form 4 as: Director, Revelation Biosciences; Chief Operating Officer, La Jolla Pharmaceutical Co.

Every Form 4 they filed

In numbers

Trades disclosed
45
Buys
5
Sells
0
Bought
$152K
Sold
$0
Companies
2
Companies where not an officer
1
First trade
4 Jan 2017
Last trade
17 Aug 2026
Last filed
18 Aug 2026

Companies traded

Where they are an officer
La Jolla Pharmaceutical CoOfficer · last 28 Feb 20195 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
REVB Revelation BiosciencesDirector · Biotechnology · last 17 Aug 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
17 Aug 2026filed 18 Aug 2026REVB Revelation BiosciencesBiotechnologySEC FORM 4 Code A—32,011 at $0.00filing
17 Aug 2026filed 18 Aug 2026REVB Revelation BiosciencesBiotechnologySEC FORM 4 Code A—32,011 at $0.00filing
3 Feb 2026filed 5 Feb 2026REVB Revelation BiosciencesBiotechnologySEC FORM 4 Code F$3,1061,661 at $1.87filing
3 Feb 2026filed 5 Feb 2026REVB Revelation BiosciencesBiotechnologySEC FORM 4 Code F$3,1061,661 at $1.87filing
8 Jan 2026filed 12 Jan 2026REVB Revelation BiosciencesBiotechnologySEC FORM 4 Code A$38K41,981 at $0.90filing
8 Jan 2026filed 12 Jan 2026REVB Revelation BiosciencesBiotechnologySEC FORM 4 Code A$38K41,981 at $0.90filing
29 Oct 2025filed 31 Oct 2025REVB Revelation BiosciencesBiotechnologySEC FORM 4 Code A$20K15,625 at $1.28filing
11 Feb 2025filed 13 Feb 2025REVB Revelation BiosciencesBiotechnologySEC FORM 4 Code A$700181 at $3.87filing
14 Apr 2023filed 18 Apr 2023REVB Revelation Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—6,356 at $0.00filing
28 Feb 2019filed 4 Mar 2019La Jolla Pharmaceutical Cooption or derivativeSEC FORM 4 Code A—230 at $0.00filing
28 Feb 2019filed 4 Mar 2019La Jolla Pharmaceutical CoSEC FORM 4 Code A$1,116230 at $4.85filing
15 Feb 2019filed 19 Feb 2019La Jolla Pharmaceutical Cooption or derivativeSEC FORM 4 Code A—230 at $0.00filing
15 Feb 2019filed 19 Feb 2019La Jolla Pharmaceutical CoSEC FORM 4 Code A$1,219230 at $5.30filing
31 Jan 2019filed 4 Feb 2019La Jolla Pharmaceutical Cooption or derivativeSEC FORM 4 Code A—1,260 at $0.00filing
31 Jan 2019filed 4 Feb 2019La Jolla Pharmaceutical CoSEC FORM 4 Code A$6,4641,260 at $5.13filing
23 Jan 2019filed 25 Jan 2019La Jolla Pharmaceutical Cooption or derivativeSEC FORM 4 Code A—53,000 at $0.00filing
15 Jan 2019filed 17 Jan 2019La Jolla Pharmaceutical Cooption or derivativeSEC FORM 4 Code A—213 at $0.00filing
15 Jan 2019filed 17 Jan 2019La Jolla Pharmaceutical CoSEC FORM 4 Code A$1,223213 at $5.74filing
9 Jan 2019filed 9 Jan 2019La Jolla Pharmaceutical CoSEC FORM 4 Bought$3,194516 at $6.19filing
9 Jan 2019filed 9 Jan 2019La Jolla Pharmaceutical CoSEC FORM 4 Bought$2,996484 at $6.19filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed5

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.